What are the current research trends in PD-L1 and nanotechnology?
Current research trends focus on: - Developing multifunctional nanoparticles that combine targeting, imaging, and therapeutic capabilities. - Investigating the use of biodegradable nanoparticles to minimize long-term toxicity. - Exploring combination therapies that use nanoparticles to deliver both PD-L1 inhibitors and other anticancer agents, such as chemotherapy or RNA interference molecules. - Studying the interaction between nanoparticles and the tumor microenvironment to enhance targeting efficiency.
